A5060385605- Nutrition and Health in Aging
- Neuroendocrine Tumor Research Advances
- Pancreatic and Hepatic Oncology Research
- Clinical Nutrition and Gastroenterology
- Neuroblastoma Research and Treatments
- Pituitary Gland Disorders and Treatments
- Head and Neck Cancer Studies
- Cancer Immunotherapy and Biomarkers
- Adrenal and Paraganglionic Tumors
- Cancer Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Frailty in Older Adults
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Oral health in cancer treatment
- Intestinal and Peritoneal Adhesions
- Metabolism, Diabetes, and Cancer
- Cancer, Lipids, and Metabolism
- Lung Cancer Research Studies
- Diet and metabolism studies
- Hormonal Regulation and Hypertension
- Stoma care and complications
- Inflammatory Biomarkers in Disease Prognosis
- Childhood Cancer Survivors' Quality of Life
- Cholangiocarcinoma and Gallbladder Cancer Studies
Institut Català d'Oncologia
2013-2024
Institut d'Investigació Biomédica de Bellvitge
2013-2024
Institut Català d'Ornitologia
2024
Universitat de Barcelona
2024
Duran i Reynals Hospital
2012-2023
Universidad de Las Palmas de Gran Canaria
2007
We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory metabolic parameters (including new-onset diabetes as a secondary endpoint) in non-diabetic hypertensive patients syndrome (MetS). A total 120 MetS stage I II hypertension were randomized to olmesartan 20 mg/amlodipine 5 mg or mg/hydrochlorothiazide 12.5 mg. If target systolic blood pressure (<140 mm Hg) was not reached, doses doubled after 13 weeks; doxazosin 4 added 26 weeks,...
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group experts in an attempt to stablish practical guidelines for diagnoses, staging and these patients. This paper summarizes main conclusions working group. Patients suspected ductal adenocarcinoma should be rapidly evaluated referred high-volume centers. Multidisciplinary supervision is critical proper frame treatment plan. Surgical resection together chemotherapy offers...
Adiposity and physical activity are modifiable factors that could be important determinants of breast cancer (BC) prognosis through their effects on endogenous reproductive hormones, chronic inflammation metabolic changes. Therefore, it is necessary to evaluate whether offering lifestyle interventions BC survivors affect the levels certain biomarkers involved in these mechanisms. We designed a pre–post intervention study diet exercise sessions over 12 weeks 42 overweight/obese survivors....
Diabetes is related with increased cancer mortality across multiple types. Its role in lung still unclear. We aim to determine the prognostic value of fasting plasma glucose (FPG) and diabetes mellitus patients locally advanced non-small cell (NSCLC) treated concurrent chemoradiotherapy.One-hundred seventy stage III NSCLC received definitive chemoradiotherapy from 2010 2014. Clinico-pathological data clinical outcome was retrospectively registered. Fifty-six (33%), met criteria for type 2...
Patient Generated Subjective Global Assessment (PG-SGA) is a validated tool for nutrition evaluation in patients with cancer.The aim of our study was to estimate the prevalence malnutrition head and neck cancer at diagnosis evaluate independent prognostic factors from PG-SGA.All outpatients attending Head Neck Cancer Multidisciplinary Meeting primary diagnosis, staging treatment were evaluated by an oncology dietitian using patient generated subjective global assessment (PG-SGA). Patients...
The objectives of our study on non-critically ill patients receiving parenteral nutrition (PN) are to assess the incidence hyperglycemia, risk factors associated its development and influence in patient's evolution.A multicentric prospective observational was performed 9 hospitals. Four multivariate studies were developed temporal occurrence hyperglycemia (endpoint), intensive care unit (ICU) admission, length stay (LOS) death. Demographics, nutrients, drugs clinical variables collected....
Central adrenal insufficiency (AI) due to isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) has been recently associated with immune checkpoint inhibitor (ICI) therapy. Our aim was analyze the prevalence, clinical characteristics, and therapeutic outcomes in cancer patients IAD induced by ICI A retrospective multicenter study performed. From a total of 4447 treated antibodies, 37 (0.8%) (23 men (62.2%), mean age 64.7 ± 8.3 years (range 46-79 years)) were diagnosed IAD. The tumor...
623 Background: Whilethe systemic inflammatory response assessed by SIRI has been recognized as a prognostic factor in advanced pancreatic cancer, understanding its association with patients' nutritional status may provide deeper insights into disease biology and outcomes. Methods: This is an observational, non-interventional multicenter study (15 Spanish hospitals) promoted SEOM, including retrospective prospectively patients metastatic cancer routine clinical practice. Clinical data was...
OBJECTIVES The objective of this study was to evaluate the feasibility point-of-care testing (POCT) devices for N-terminal pro-B-type natriuretic peptide (NT-proBNP) measurement in prehospital settings, with aim improving speed and accuracy stroke diagnosis, thereby facilitating quicker more effective patient care.
Background: Everolimus, an oral inhibitor of the mammalian target rapamycin (mTOR), is actually used to prevent organ transplant rejection and treat metastatic breast, renal, neuroendocrine cancers. Despite significant pharmacokinetic variability among patients, routine therapeutic drug monitoring (TDM) not commonly in oncology. Methods: The aim this multicenter, prospective observational cohort study assess prevalence everolimus minimum concentration at a steady state (Cminss) falling...